Chargement en cours...
Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout
BACKGROUND: Long term serum urate (SU) lowering to a target of <0.36 mmol/l (6 mg/dl) is recommended for effective gout management. However, many studies have reported low achievement of SU targets. The aim of this cross-sectional study was to examine the clinical and psychological factors associ...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3493372/ https://ncbi.nlm.nih.gov/pubmed/22978848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2474-13-174 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|